This study offers a comprehensive analysis of the global IoT security market, including current and future trends, to identify potential investment opportunities. The report provides insights into key ...
GSK’s FIRST-ENGOT-OV44 phase III clinical trial of Zejula and Jemperl in first line advanced ovarian cancer meets primary endpoint: London Saturday, December 21, 2024, 09:00 Hrs ...